Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone for acute subjective tinnitus
NCT05591144Completed
- Sponsor
- Eye and ENT Hospital of Fudan University
- Start
- Oct 2022
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of prednisone in tinnitus (2 arms), sponsored by Eye and ENT Hospital of Fudan University. Primary endpoint: Tinnitus Handicap Inventory at 12 weeks. Started Oct 2022; status: completed.
02
Drugs
prednisone
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT05591144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05591144.